✦ LIBER ✦

The cost-effectiveness of infliximab (Remicade(R)) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study

✍ Scribed by Kobelt, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AR2 A COST EFFECTIVENESS ANALYSIS OF INF

✍ I Lekander; F Borgström; C Carli; P Svarvar; T Ljung; R van Vollenhoven 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PMS15 COST-EFFECTIVENESS OF THE TREATMEN

✍ E Mucino; R Rivas; L Zapata 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

The Comparison of Trial Data–Based and R

✍ Lekander, Ingrid; Kobelt, Gisela; Svarvar, Patrick; Ljung, Tryggve; van Vollenho 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB

PMS49 Cost-Effectiveness Analysis of Eta

✍ P. Guijarro; C. Crespo; M. Brosa 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Infliximab and Methotrexate in the Treat

✍ Lipsky, Peter E.; van der Heijde, Desiree M.F.M.; St. Clair, E. William; Furst, 📂 Article 📅 2000 🏛 Massachusetts Medical Society 🌐 English ⚖ 131 KB

Outcome of pregnancy in women receiving

✍ Jeffry A. Katz; Gary R. Lichtenstein; Gregory F. Keenan; Deirdre E. Healy; Steph 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 199 KB